SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Mario Cornejo-Olivas, Luis Torres, Ignacio F. Mata, Pilar Mazzetti, Diana Rivas, Carlos Cosentino, Miguel Inca-Martinez, Juan M. Cuba, Cyrus P. Zabetian, James B. Leverenz, A Peruvian family with a novel PARK2 mutation: Clinical and Pathological Characteristics, Parkinsonism & Related Disorders, 2015,

    CrossRef

  2. 2
    Sheng Deng, Xiong Deng, Lamei Yuan, Zhi Song, Zhijian Yang, Wei Xiong, Hao Deng, Genetic analysis of SNCA coding mutation in Chinese Han patients with Parkinson disease, Acta Neurologica Belgica, 2014,

    CrossRef

  3. 3
    Hao Deng, Lamei Yuan, Genetic variants and animal models in SNCA and Parkinson disease, Ageing Research Reviews, 2014, 15, 161

    CrossRef

  4. 4
    Karla Cristina Vasconcelos Moura, Mário Campos Junior, Ana Lúcia Zuma de Rosso, Denise Hack Nicaretta, João Santos Pereira, Delson José Silva, Flávia Lima dos Santos, Fabíola da Costa Rodrigues, Cíntia Barros Santos-Rebouças, Márcia Mattos Gonçalves Pimentel, Genetic Analysis ofPARK2andPINK1Genes in Brazilian Patients with Early-Onset Parkinson's Disease, Disease Markers, 2013, 35, 181

    CrossRef

  5. 5
    Xiao-Yang Liao, Wei-Wen Wang, Zheng-Hui Yang, Jun Wang, Hang Lin, Qing-Song Wang, Yu-Xian Wu, Yu Liu, Microarray Analysis of Transcriptome of Medulla Identifies Potential Biomarkers for Parkinson’s Disease, International Journal of Genomics, 2013, 2013, 1

    CrossRef

  6. 6
    Emilia Mabel Gatto, Virginia Parisi, Daniela Paola Converso, Juan José Poderoso, María Cecilia Carreras, José Felix Martí-Massó, Coro Paisán-Ruiz, The LRRK2 G2019S mutation in a series of Argentinean patients with Parkinson's disease: Clinical and demographic characteristics, Neuroscience Letters, 2013, 537, 1

    CrossRef

  7. 7
    Mohamed M. Jahromi, Haplotype specific alteration of diabetes MHC risk by olfactory receptor gene polymorphism, Autoimmunity Reviews, 2012, 12, 2, 270

    CrossRef

  8. 8
    Raúl de la Fuente-Fernández, Michael Schulzer, Lisa Kuramoto, Jacquelyn Cragg, Nandhagopal Ramachandiran, Wing L. Au, Edwin Mak, Jess McKenzie, Siobhan McCormick, Vesna Sossi, Thomas J. Ruth, Chong S. Lee, Donald B. Calne, A. Jon Stoessl, Age-specific progression of nigrostriatal dysfunction in Parkinson's disease, Annals of Neurology, 2011, 69, 5
  9. 9
    Changshui Xu, Jun Xu, Yanmin Zhang, Jianjun Ma, Hideshi Kawakami, Hirofumi Maruyama, Masaki Kamada, Analysis on the Susceptibility Genes in Two Chinese Pedigrees with Familial Parkinson's Disease, Neurology Research International, 2010, 2010, 1

    CrossRef

  10. 10
    Barbara Jasinska-Myga, Jennifer Kachergus, Carles Vilariño-Güell, Christian Wider, Alexandra I. Soto-Ortolaza, Mounir Kefi, Lefkos T. Middleton, Lianna Ishihara-Paul, Rachel A. Gibson, Rim Amouri, Samia Ben Yahmed, Samia Ben Sassi, Mourad Zouari, Ghada El Euch, Owen A. Ross, Faycal Hentati, Matthew J. Farrer, Comprehensive sequencing of the LRRK2 gene in patients with familial Parkinson's disease from North Africa, Movement Disorders, 2010, 25, 13
  11. 11
    Karen Nuytemans, Jessie Theuns, Marc Cruts, Christine Van Broeckhoven, Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update, Human Mutation, 2010, 31, 7
  12. 12
    L. Samaranch, O. Lorenzo-Betancor, J. M. Arbelo, I. Ferrer, E. Lorenzo, J. Irigoyen, M. A. Pastor, C. Marrero, C. Isla, J. Herrera-Henriquez, P. Pastor, PINK1-linked parkinsonism is associated with Lewy body pathology, Brain, 2010, 133, 4, 1128

    CrossRef